Abacavir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Major Pharmaceuticals. The primary component is Abacavir Sulfate.
Product ID | 0904-6874_0e90adf2-8931-4df2-b501-0217ca0b822a |
NDC | 0904-6874 |
Product Type | Human Prescription Drug |
Proprietary Name | Abacavir |
Generic Name | Abacavir |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2012-12-17 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA077844 |
Labeler Name | Major Pharmaceuticals |
Substance Name | ABACAVIR SULFATE |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 1A1 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2012-12-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA077844 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-12-17 |
Marketing Category | ANDA |
Application Number | ANDA077844 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-12-17 |
Ingredient | Strength |
---|---|
ABACAVIR SULFATE | 300 mg/1 |
SPL SET ID: | 4b286ec6-68a7-4ec0-af07-5a27ec9cb35d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0121-0897 | Abacavir | Abacavir |
0904-6874 | Abacavir | Abacavir |
31722-557 | Abacavir | Abacavir |
31722-562 | Abacavir | Abacavir |
50268-049 | Abacavir | Abacavir |
64380-717 | Abacavir | Abacavir |
64980-405 | Abacavir | Abacavir Sulfate |
65862-073 | Abacavir | Abacavir |
65862-089 | Abacavir | Abacavir Sulfate |
68084-021 | Abacavir | Abacavir Sulfate |
69097-514 | Abacavir | Abacavir |
70518-0559 | Abacavir | Abacavir |
70518-1274 | Abacavir | Abacavir |
72865-167 | Abacavir | Abacavir |